Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

64results about How to "Prevent and reduce incidence" patented technology

Cargo container cradle

A modular cradle for reinforcing, transporting, and stacking cargo containers used in the transportation and storage of bulk cargo in the oil and gas industry so as to allow compliance with construction and shipping standards adopted by the oil and gas industry is disclosed. The cargo cradle is comprised of a rectangular frame for holding and supporting a cargo container. The cradle has attached lifting lugs positioned within the interior of the cargo cradle for attachment of lifting cables. The lifting lugs are positioned so as to allow cradles to be stacked one upon the other. The container cradles interlock when stacked.
Owner:R3G

System for providing a medical device with anti-microbial properties

A system for providing medical device with anti-microbial properties to prevent infections. The system includes a medical device having a portion for insertion into the body of a patient, a lumen, and a substrate comprising an anti-microbial agent to be inserted into the lumen of the medical device. To protect the substrate from anti-microbial agents during insertion into the lumen, the system further includes a collapsible cover connected to the substrate. A connector can be used for attaching the substrate to the cover. The substrate may be an iodine-based rod. A guidewire may be attached to the connector to further facilitate insertion of the substrate into the lumen.
Owner:BOSTON SCI SCIMED INC

Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists

InactiveUS20060147450A1Treating and preventing and reducing incidence of NGF-associatedPrevent and reduce incidenceImmunoglobulins against growth factorsAntibody ingredientsCardiac disordersCardiac arrhythmia
This invention relates to the field of cardiac disease. More specifically, the invention relates to methods using an NGF antagonist for treating and preventing cardiac arrhythmia and methods of preventing death due to cardiac arrhythmia.
Owner:RINAT NEUROSCI CORP

Formulations for oral administration of cromolyn sodium

An oral dosage form comprises cromolyn sodium (sodium or disodium cromoglycate), and an acylated amino acid delivery agent.
Owner:NOVO NORDISK NORTH AMERICA OPERATIONS AS

Aeroponic growing apparatus and method

Apparatus and method for improving aeroponic horticulture growing efficiency by delivering air and atomized liquid nutrient to plant roots in a manner that preserves and encourages root hair growth. The disclosed aeroponic system includes a nozzle for varying the particle size distribution and flow rate of an atomized liquid nutrient. In one embodiment, a significant portion of the atomized liquid droplets are less than 30 microns in size.
Owner:RARING DAVID

Compositions and Methods for Treating or Preventing Inflammatory Bowel Disease, Familial Adenomatous Polyposis and Colon Cancer

The present invention provides methods for preventing colon cancer by administering, to a patient in need thereof, a polymeric proanthocyanidin composition from a Croton species or Calophyllum species in an amount sufficient to prevent colon cancer, which composition inhibits COX-2. The present invention also provides methods for treating inflammation locally in the intestines comprising administering to a patient in need thereof, a polymeric proanthocyanidin composition from a Croton species or Calophyllum species in an amount sufficient to treat inflammation. In one embodiment, the polymeric proanthocyanidin compound is crofelemer. The present invention in alternative embodiments provides methods for treating pain locally in the intestines and treating inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, as well as for treating familial adenomatous polyposis (FAP).
Owner:NAPO PHARMA INC

Light Sensing Circuit, Method Of Manufacturing The Same, And Optical Touch Panel Including The Light Sensing Circuit

A light sensing circuit using an oxide semiconductor transistor, a method of manufacturing the light sensing circuit, and an optical touch panel including the light sensing circuit. Because the light sensing circuit includes only one light sensor transistor and one switch transistor formed on the same substrate, a structure of the light sensing circuit is simplified. Furthermore, because the light sensor transistor and the switch transistor have the same structure, a method of manufacturing the light sensing circuit is also simplified. Also, since an optical touch panel or an image acquisition apparatus using the light sensing circuit uses the light sensing circuit having a simple structure and does not use a capacitor, the optical touch panel or the image acquisition apparatus may be made thinner and larger.
Owner:SAMSUNG ELECTRONICS CO LTD

Welding wire spool and drive cartridge

InactiveUS20060157461A1Changed out quickly and easilyFast and efficientElectrode supporting devicesEngineeringHousing design
A modular welding wire cartridge for use in a welding system. The welding wire cartridge is designed to be detachably connected to the welding wire feed system of the welding system. The welding wire cartridge includes a drive housing designed to be detachably connectable to the welding wire feed system, a wire contact arrangement designed to controllably feed welding wire through the welding wire cartridge, and a spool of welding wire.
Owner:LINCOLN GLOBAL INC

Modular building construction systems and methods

Implementations of the present invention relate to systems, methods, and apparatus for constructing a building. More specifically, the present disclosure provides an interlocking wall system that can allow a builder to accurately position, orient, and / or secure various structural wall modules. Additionally, this disclosure provides systems and methods for securing one or more cladding layers to the building's envelope. Furthermore, implementations of the present disclosure can allow for quick and modifiable installation of utility and communication lines within the building.
Owner:DIRTT ENVIRONMENTAL SOLUTIONS

Method of Treating Neurological Conditions with Oleandrin

A method of treating neurological condition in a subject by administration of a cardiac glycoside is provided. Alzheimer's disease, Huntington's disease or stroke are treated by administering a therapeutically effective amount of cardiac glycoside, and optionally triterpene(s), to a subject. The cardiac glycoside can be present in a dosage form.
Owner:PHOENIX BIOTECH INC

Wound or skin treatment devices and methods

Devices, kits and methods described herein may be for treatment to skin, including but not limited to wound healing, the treatment, amelioration, and / or prevention of scars or keloids. A book-like packaging, applicator and / or tensioning device may be used to apply a dressing to a subject. The packaging, applicator and / or tensioning device may apply and / or maintain a strain in an elastic dressing.
Owner:NEODYNE BIOSCI INC

Treatment of mucositis using N-acetylcysteine

This present invention provides a therapeutic composition for use in the treatment of mucositis and a method for using such a therapeutic composition. The therapeutic composition includes a pharmaceutical substance effective for treating mucositis formulated with a biocompatible polymer, such as a biocompatible reverse-thermal gelation polymer.
Owner:RXKINETIX

Temporary pharmacologically-inactive dental coating for the in situ protection of dental therapeutic agents from saliva and abrasion from chewing

Topical application of a pharmacologically-inactive, inert polymeric solution to teeth affords a temporary, protective barrier for pharmacologically-active compounds that have been previously applied topically to the tooth surfaces for caries reduction. In a method of use, an aqueous dispersion polymethylmethacrylate (PMMA) and a suitable plasticizer are applied topically to the tooth surface immediately after the topical application of chlorhexidine or fluoride. The inert coating thus formed is distinct from any pharmacologically-active substance, and remains on the tooth surface until abraded by the chewing of hard foods. In a composition of matter, the solution contains ammonio methacrylate copolymer, type B USP / NF of between 20% and 35% w / w; triethyl citrate USP / NF of between 1% and 10% w / w; and purified water of between 60% and 70% w / w. The ammonio methacrylate copolymer is preferably EUDRAGIT RS 30 D brand available form Rohm GmbH.
Owner:SYMINGTON JOHNM +2

Dextrin containing compositions for prevention of adhesions

A composition for the treatment of adhesions that are formed as a result of an inflammatory response comprising an aqueous formulation containing the polysaccharide dextrin in an effective amount. The invention also discloses a method of treating adhesions that are formed as a result of an inflammatory response.
Owner:INNOVATA LTD

Reducing Myocardial Damage and the Incidence of Arrhythmia Arising From Loss, Reduction or Interruption in Coronary Blood Flow

A method and pharmaceutical composition are disclosed for treating, ameliorating and / or preventing one or more myocardial disorders in a mammalian heart caused by a myocardial hypoxic event and / or a loss, reduction or interruption in coronary blood flow such as may happen during or after events such as a heart attack, cardiac surgery including coronary artery bypass graft, or coronary artery or myocardial reperfusion. The myocardial disorders include myocardial arrhythmias, myocardial damage and myocardial cell death, and the subsequent loss of haemodynamic function. The myocardial disorders could be in progress or suspected of being in progress at the time of treatment or could be anticipated disorders being treated prophylactically. The method involves the step of administering an effective amount of the composition. The composition comprises as its active ingredient one or more compounds having myocardial persistent sodium channel blocking activity. A preferred compound is riluzole or a salt or derivative thereof.
Owner:WEISS STEVEN MICHAEL

Systems genetics network regulators as drug targets

InactiveUS20150252409A1Preventing and reducing incidencePreventing and reducing and severityOrganic active ingredientsMicrobiological testing/measurementHepatocellular carcinomaDrug target
The present invention provides for methods, processes and platforms to validate systems genetics networks to define their genetic regulators and to optimize translational applicability to humans for drug development. These systems genetics networks are sets of genes with a common function that demonstrate covariate expression that is genetically modulated by linked function network regulators (LFNRs) which comprise eQTLs in animals and GWAS SNPs in humans. LFNRs represent a new class of targets to identify drugs to prevent, ameliorate, and / or treat human diseases. LFNRs for the cell cycle-mitosis network have potential to be especially useful for anti-cancer therapies. The present invention provides for a drug that targets a specific LFNR for the cell cycle-mitosis network in Caucasian male liver to prevent the development of hepatocellular carcinoma in high risk patient populations.
Owner:SCOTT ROBERT E

Method of treating neurological conditions with oleandrin

A method of treating neurological condition in a subject by administration of a cardiac glycoside is provided. Alzheimer's disease, Huntington's disease or stroke are treated by administering a therapeutically effective amount of cardiac glycoside, and optionally triterpene(s), to a subject. The cardiac glycoside can be present in a dosage form.
Owner:PHOENIX BIOTECH INC

Treatment of esophagitis

A method for treatment of esophagitis is disclosed in which a therapeutic composition is introduced into the esophagus to contact a mucosal surface within the esophagus. The pharmaceutical composition comprises a reverse-thermal gelation polyoxyalkylene block copolymer, a pharmaceutical substance and a pharmaceutical substance selected from the group consisting of glutathione and a precursor for glutathione biosynthesis.
Owner:ENDO PHARMA COLORADO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products